Recently, the National Comprehensive Cancer Network (NCCN) Guidelines for Head and Neck Cancers expanded to include proton beam therapy (PBT) as an appropriate treatment option in specific cases – particularly tumors in and around the obit of the eye and base of the skull. Proton therapy has also been shown to be beneficial in curative cases of head and neck cancers or when there is long life expectancy.
Recognizing the value of the advanced radiation therapy technology, NCCN acknowledged PBT might offer certain clinical advantages when it comes to sparing important organs such as the brain, brain stem, nerve networks, inner ear and eye as well as structures in the mouth and throat. While effectively controlling the primary tumor, proton therapy diminishes damage to normal tissue and may also reduce the risk of late tissue damage.
Since proton therapy results in significantly less radiation dose to normal tissue, the treatment offers numerous long-term benefits for head and neck cancers, including the following:
The Mevion S250 Proton Therapy System at Ackerman Cancer Center offers full robotic positioning to ensure precise tumor targeting and features DirectDose(tm) beam modulating technology. The high level accuracy of this proton therapy delivery system, along with the experience of our expert radiation oncologists and staff, helps ensure exposure to healthy surrounding tissues and organs is minimized, significantly reducing the risk of unpleasant side effects.
If you have any questions or want to find out more about proton therapy for head and neck cancers, call the Ackerman Cancer Center office at (904) 880-5522.